Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 12Unknown 3Withdrawn 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 5Colorectal Neoplasms 4Squamous Cell Carcinoma of Head and Neck 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Colonic Neoplasms 2Tongue Neoplasms 1Melanoma 1Localized Resectable Adult Primary Liver Cancer 1Liver Neoplasms 1Head and Neck Neoplasms 1Gallbladder Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Hepatocellular 1Bile Duct Neoplasms 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Cisplatin 12Cetuximab 9pembrolizumab 7Radiotherapy 7Fluorouracil 6Carboplatin 5Radiotherapy, Intensity-Modulated 4Nivolumab 4epacadostat 3Radiation 3Docetaxel 3Venlafaxine Hydrochloride 2Surveys and Questionnaires 2Panitumumab 2Paclitaxel 2Ketamine 2zimberelimab 1vandetanib 1tislelizumab 1temsirolimus 1ruxolitinib 1plerixafor 1nimotuzumab 1linrodostat 1fosbretabulin 1fluoromisonidazole 1fludarabine phosphate 1fludarabine 1elgemtumab 1ebselen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Head and Neck Neoplasms × Chemotherapy, Adjuvant × Clear all
NCT01142414 2012-01-16

Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Withdrawn
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡